Clinical and Biological Factors With Prognostic Value in Acute Pancreatitis
Abstract
:Introduction
Materials and Methods
Results
Criteria | Sensitivity | Specificity | VPP | VPN | p-value |
Age | 0.50 | 0.61 | 0.12 | 0.89 | 0.02* |
Leukocyte | 0.40 | 0.82 | 0.22 | 0.83 | 0.06 |
Glucose | 0.12 | 0.72 | 0.21 | 0.82 | 0.32 |
ASAT | 0.21 | 0.63 | 0.07 | 0.82 | 0.83 |
Hematocrit | 0.22 | 0.63 | 0.10 | 0.82 | 0.60 |
Calcium | 0.52 | 0.81 | 0.27 | 0.90 | 0.02* |
Urea | 0.22 | 0.83 | 0.31 | 0.90 | 0.08 |
PaO2 | 0.58 | 0.64 | 0.37 | 0.85 | 0.07 |
Parameter | Ranson | Apache II 24 h |
Sensitivity | 81% | 81% |
Specificity | 68% | 75% |
Positive predictive value | 37% | 45% |
Negative predictive value | 95% | 95% |
P value | <0.001 | <0.001 |
Discussion
Conclusions
Conflicts of Interest disclosure
Compliance with ethical standards
References
- Constantinoiu, S.; Cochior, D. Severe Acute Pancreatitis-Determinant Factors and Current Therapeutic Conduct. Chirurgia (Bucur). 2018, 113, 385–390. [Google Scholar] [CrossRef]
- Ouyang, G.; Pan, G.; Liu, Q.; Wu, Y.; Liu, Z.; Lu, W.; Li, S.; Zhou, Z.; Wen, Y. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. BMC Med. 2020, 18, 388. [Google Scholar] [CrossRef]
- Garg, S.K.; Campbell, J.P.; Anugwom, C.; Wadhwa, V.; Singh, R.; Gupta, N.; Sanaka, M.R. Incidence and Predictors of Readmissions in Acute Pancreatitis: A Nationwide Analysis. Pancreas. 2018, 47, 46–54. [Google Scholar] [CrossRef]
- Pintado, M.C.; Trascasa, M.; Arenillas, C.; de Zárate, Y.O.; Pardo, A.; Blandino Ortiz, A.; de Pablo, R. New Atlanta Classification of acute pancreatitis in intensive care unit: Complications and prognosis. Eur J Intern Med. 2016, 30, 82–87. [Google Scholar] [CrossRef]
- Serban, D.; Socea, B.; Badiu, C.D.; Tudor, C.; Balasescu, S.A.; Dumitrescu, D.; Trotea, A.M.; Spataru, R.I.; Vancea, G.; Dascalu, A.M.; Tanasescu, C. Acute surgical abdomen during the COVID-19 pandemic: Clinical and therapeutic challenges. Exp Ther Med. 2021, 21, 519. [Google Scholar] [CrossRef] [PubMed]
- Șerban, D.; Brănescu, C.M.; Smarandache, G.C.; Tudor, C.; Tănăsescu, C.; Tudosie, M.S.; Stana, D.; Costea, D.O.; Dascălu, A.M.; Spătaru, R.I. Safe surgery in day care centers: focus on preventing medical legal issues. Rom J Leg Med. 2021, 29, 60–64. [Google Scholar] [CrossRef]
- Serban, D.; Smarandache, A.M.; Cristian, D.; Tudor, C.; Duta, L.; Dascalu, A.M. Medical errors and patient safety culture - shifting the healthcare paradigm in Romanian hospitals. Rom J Leg Med. 2020, 28, 195–201. [Google Scholar] [CrossRef]
- Pintado, M.C.; Trascasa, M.; Arenillas, C.; de Zárate, Y.O.; Pardo, A.; Blandino Ortiz, A.; de Pablo, R. New Atlanta Classification of acute pancreatitis in intensive care unit: Complications and prognosis. Eur J Intern Med. 2016, 30, 82–87. [Google Scholar] [CrossRef]
- James, T.W.; Crockett, S.D. Management of acute pancreatitis in the first 72 hours. Curr Opin Gastroenterol. 2018, 34, 330–335. [Google Scholar] [CrossRef] [PubMed]
- Yadav, D.; O'Connell, M.; Papachristou, G.I. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol. 2012, 107, 1096–1103. [Google Scholar] [CrossRef]
- Fonseca Sepúlveda, E.V.; Guerrero-Lozano, R. Acute pancreatitis and recurrent acute pancreatitis: an exploration of clinical and etiologic factors and outcomes. J Pediatr (Rio J). 2019, 95, 713–719. [Google Scholar] [CrossRef] [PubMed]
- Savlovschi, C.; Brănescu, C.; Serban, D.; Tudor, C.; Găvan, C.; Shanabli, A.; Comandaşu, M.; Vasilescu, L.; Borcan, R.; Dumitrescu, D.; Sandolache, B.; Sajin, M.; Grădinaru, S.; Munteanu, R.; Kraft, A.; Oprescu, S. Amyand's hernia--a clinical case. Chirurgia (Bucur). 2010, 105, 409–414. [Google Scholar]
- Serban, D.; Tribus, L.C.; Vancea, G.; Stoian, A.P.; Dascalu, A.M.; Suceveanu, A.I.; Tanasescu, C.; Costea, A.C.; Tudosie, M.S.; Tudor, C.; Gangura, G.A.; Duta, L.; Costea, D.O. Acute Mesenteric Ischemia in COVID-19 Patients. J Clin Med. 2021, 11, 200. [Google Scholar] [CrossRef]
- Machicado, J.D.; Yadav, D. Epidemiology of Recurrent Acute and Chronic Pancreatitis: Similarities and Differences. Dig Dis Sci. 2017, 62, 1683–1691. [Google Scholar] [CrossRef]
- Greenberg, J.A.; Hsu, J.; Bawazeer, M.; Marshall, J.; Friedrich, J.O.; Nathens, A.; Coburn, N.; May, G.R.; Pearsall, E.; McLeod, R.S. Clinical practice guideline: management of acute pancreatitis. Can J Surg. 2016, 59, 128–140. [Google Scholar] [CrossRef]
- Goyal, H.; Awad, H.; Hu, Z.D. Prognostic value of admission red blood cell distribution width in acute pancreatitis: a systematic review. Ann Transl Med. 2017, 5, 342. [Google Scholar] [CrossRef] [PubMed]
- Gravito-Soares, M.; Gravito-Soares, E.; Gomes, D.; Almeida, N.; Tomé, L. Red cell distribution width and red cell distribution width to total serum calcium ratio as major predictors of severity and mortality in acute pancreatitis. BMC Gastroenterol. 2018, 18, 108. [Google Scholar] [CrossRef] [PubMed]
- Soyalp, M.; Yalcin, M.; Oter, V.; Ozgonul, A. Investigation of procalcitonin, IL-6, oxidative stress index (OSI) plasma and tissue levels in experimental mild and severe pancreatitis in rats. Bratisl Lek Listy. 2017, 118, 137–141. [Google Scholar] [CrossRef]
- Ekremoğlu, M.; Severcan, Ç.; Pasaoğlu, Ö.T.; Şen, B.; Pasaoğlu, H. An investigation of acute effects at various doses of malathion on glucose homeostasis and insulin resistance in rat liver, pancreas and serum. J Mind Med Sci. 2020, 7, 85–93. [Google Scholar] [CrossRef]
- Gray, S.H.; Rosenman, L.D. Acute pancreatitis. The significance of hemoconcentration at admission to the hospital. Arch Surg. 1965, 91, 485–489. [Google Scholar] [CrossRef]
- Talamini, G.; Bassi, C.; Falconi, M.; Sartori, N.; Frulloni, L.; Di Francesco, V.; Vesentini, S.; Pederzoli, P.; Cavallini, G. Risk of death from acute pancreatitis. Role of early, simple “routine” data. Int J Pancreatol. 1996, 19, 15–24. [Google Scholar] [CrossRef] [PubMed]
- Remes-Troche, J.M.; Duarte-Rojo, A.; Morales, G.; Robles-Díaz, G. Hemoconcentration is a poor predictor of severity in acute pancreatitis. World J Gastroenterol. 2005, 11, 7018–7023. [Google Scholar] [CrossRef]
- Rompianesi, G.; Hann, A.; Komolafe, O.; Pereira, S.P.; Davidson, B.R.; Gurusamy, K.S. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev. 2017, 4, CD012010. [Google Scholar] [CrossRef]
- Conwell, D.L.; Lee, L.S.; Yadav, D.; Longnecker, D.S.; Miller, F.H.; Mortele, K.J.; Levy, M.J.; Kwon, R.; Lieb, J.G.; Stevens, T.; Toskes, P.P.; Gardner, T.B.; Gelrud, A.; Wu, B.U.; Forsmark, C.E.; Vege, S.S. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014, 43, 1143–1162. [Google Scholar] [CrossRef] [PubMed]
- Muddana, V.; Whitcomb, D.C.; Khalid, A.; Slivka, A.; Papachristou, G.I. Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis. Am J Gastroenterol. 2009, 104, 164–170. [Google Scholar] [CrossRef]
- Ranson, J.H.; Rifkind, K.M.; Roses, D.F.; Fink, S.D.; Eng, K.; Spencer, F.C. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974, 139, 69–81. [Google Scholar]
- Şurlin, V.; Săftoiu, A.; Dumitrescu, D. Imaging tests for accurate diagnosis of acute biliary pancreatitis. World J Gastroenterol. 2014, 20, 16544–16549. [Google Scholar] [CrossRef]
- Shahzad, N.; Khan, M.R.; Inam Pal, K.M.; Khan, D.B.; Effendi, M.S. Role of early contrast enhanced CT scan in severity prediction of acute pancreatitis. J Pak Med Assoc. 2017, 67, 923–925. [Google Scholar]
- Balthazar, E.J.; Ranson, J.H.; Naidich, D.P.; Megibow, A.J.; Caccavale, R.; Cooper, M.M. Acute pancreatitis: prognostic value of CT. Radiology. 1985, 156, 767–772. [Google Scholar] [CrossRef]
- Dervenis, C.; Johnson, C.D.; Bassi, C.; Bradley, E.; Imrie, C.W.; McMahon, M.J.; Modlin, I. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol. 1999, 25, 195–210. [Google Scholar] [CrossRef]
- Harshit Kumar, A.; Singh Griwan, M. A comparison of APACHE II, BISAP, Ranson's score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta Classification. Gastroenterol Rep (Oxf). 2018, 6, 127–131. [Google Scholar] [CrossRef]
- Machicado, J.D.; Gougol, A.; Tan, X.; Gao, X.; Paragomi, P.; Pothoulakis, I.; et al. Mortality in acute pancreatitis with persistent organ failure is determined by the number, type, and sequence of organ systems affected. United European Gastroenterol J. 2021, 9, 139–149. [Google Scholar] [CrossRef]
- Shi, N.; Liu, T.; de la Iglesia-Garcia, D.; Deng, L.; Jin, T.; Lan, L.; Zhu, P.; Hu, W.; Zhou, Z.; Singh, V.; Dominguez-Munoz, J.E.; Windsor, J.; Huang, W.; Xia, Q.; Sutton, R. Duration of organ failure impacts mortality in acute pancreatitis. Gut. 2020, 69, 604–605. [Google Scholar] [CrossRef]
- Naveena, R.M. Clinical spectrum of obstructive jaundice: a descriptive cross-sectional study. J Clin Invest Surg. 2021, 6, 53–57. [Google Scholar] [CrossRef]
- Pantea Stoian, A.M.; Ditu, G.; Diculescu, M.; Manuc, M.; Suceveanu, A.I.; Manuc, D.; Diaconu, C.; Suceveanu, A.P.; Nitipir, C.; Hainarosie, R.; Poiana, C.; Serafinceanu, C. Pancreatogenic type 3C diabetes. J Mind Med Sci. 2018, 5, 270–277. [Google Scholar] [CrossRef]
- Gheorghe, G.; Stoian, A.P.; Gaman, M.A.; Socea, B.; Neagu, T.P.; Stanescu AMABratu, O.G.; Mischianu, D.; Suceveanu, A.I.; Diaconu, C.C. The Benefits and Risks of Antioxidant Treatment in Liver Diseases. Rev Chim(Buc). 2019, 70, 651–655. [Google Scholar]
- Busnatu, S.S.; Salmen, T.; Pana, M.A.; Rizzo, M.; Stallone, T.; Papanas, N.; Popovic, D.; Tanasescu, D.; Serban, D.; Stoian, A.P. The Role of Fructose as a Cardiovascular Risk Factor: An Update. Metabolites. 2022, 12, 67. [Google Scholar] [CrossRef]
- Ardeleanu, V.; Toma, A.; Pafili, K.; Papanas, N.; Motofei, I.; Diaconu, C.C.; Rizzo, M.; Stoian, A.P. Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review. Medicina (Kaunas). 2020, 56, 25. [Google Scholar] [CrossRef]
- Draghici, T.; Negreanu, L.; Bratu, O.G.; Stoian, A.P.; Socea, B.; Neagu, T.P.; Stanescu, A.M.A.; Manuc, D.; Diaconu, C.C. Paraneoplastic syndromes in digestive tumors: a review. Rom Biotechnol Lett. 2019, 24, 813–819. [Google Scholar] [CrossRef]
- Şavlovschi, C.; Comandaşu, M.; Şerban, D. Specifics of diagnosis and treatment in synchronous colorectal cancers (SCC). Chirurgia (Bucur). 2013, 108, 43–45. [Google Scholar]
- Fometescu, S.G.; Costache, M.; Coveney, A.; Oprescu, S.M.; Serban, D.; Savlovschi, C. Peritoneal fibrinolytic activity and adhesiogenesis. Chirurgia (Bucur). 2013, 108, 331–340. [Google Scholar] [PubMed]
- Shen, H.N.; Chang, Y.H.; Chen, H.F.; Lu, C.L.; Li, C.Y. Increased risk of severe acute pancreatitis in patients with diabetes. Diabet Med. 2012, 29, 1419–1424. [Google Scholar] [CrossRef] [PubMed]
Parameter | No of cases (%) |
---|---|
AP etiology: | |
Biliary | 53(44.9%) |
Alcoholic | 37 (31.3%) |
Metabolic | 6 (5%) |
Posttraumatic | 2 (1.6%) |
After surgery | 9 (7.6%) |
Idiopathic | 11(9.3%) |
Comorbidities: | |
Arterial hypertension | 45(38.1%) |
Diabetes | 13(11%) |
Ischemic cardiac diseases | 23(19.5%) |
Respiratory diseases | 5 (4.2%) |
Time elapsed since the onset of | |
symptoms: | |
24-48 h | 5 (4.3%) |
48-72 h | 47(39.8%) |
3-5 days | 35 (29.6%) |
5-7 days | 31 (26.3%) |
AP form: | |
Mild | 86 (72.8%) |
Severe | 32 (27.2%) |
Mild form (n=86) | Sever form (n=32) | Total | p | ||||||||||||||
Ht. at admission | 18 | 23 | 41 | ||||||||||||||
Ht. at 24 h | 24 | 8 | 32 | ||||||||||||||
Hb. at admission (mg/dl) | 8-10 | 10-12 | 12-14 | 14-16 | >16 | 8-10 | 10-12 | 12-14 | 14-16 | >16 | |||||||
1 | 5 | 52 | 26 | 2 | 17 | 6 | 9 | 0 | 0 | ||||||||
Hb. at 72 h | 0 | 0 | 83 | 3 | 0 | 0 | 9 | 22 | 1 | 0 | |||||||
Leukocytes at admission (e/dl) | 4000- 9000 | 9000- 10000 | 10000- 150000 | 15000- 20000 | 4000- 9000 | 9000- 10000 | 10000- 15000 | 15000- 20000 | >20000 | ||||||||
8 | 3 | 53 | 22 | 0 | 0 | 2 | 8 | 22 | |||||||||
Leukocytes at 72h | 17 | 43 | 19 | 7 | 0 | 4 | 5 | 8 | 15 | ||||||||
Leukocytes at discharge | 67 | 19 | 0 | 0 | 25 | 5 | 2 | 0 | 0 | ||||||||
Amylases at admission | <25 u/l | 25-125 u/l | 3x125 u/l | 5x125u/l | 118 | ||||||||||||
2 | 20 | 37 | 59 | ||||||||||||||
Creatinine at admission | <1.8 mg/dl | >1.8 mg/dl | <1.8 mg/dl | >1.8 mg/dl | 85 | <0.001 | |||||||||||
19 | 39 | 15 | 12 | ||||||||||||||
Creatinine at 48 h | <1.8 mg/dl | >1.8 mg/dl | <1.8 mg/dl | >1.8 mg/dl | 118 | <0.0001 | |||||||||||
71 | 15 | 11 | 21 |
© 2022 by the author. 2022 Mihai Faur, Dan Dumitrescu, Dan Sabau, Ciprian Tanasescu, Dan Cretu, Denisa Tanasescu, Vlad Denis Constantin, Calin Mohor 1,2
Share and Cite
Faur, M.; Dumitrescu, D.; Sabau, D.; Tanasescu, C.; Cretu, D.; Tanasescu, D.; Constantin, V.D.; Mohor, C. Clinical and Biological Factors With Prognostic Value in Acute Pancreatitis. J. Mind Med. Sci. 2022, 9, 310-317. https://doi.org/10.22543/2392-7674.1352
Faur M, Dumitrescu D, Sabau D, Tanasescu C, Cretu D, Tanasescu D, Constantin VD, Mohor C. Clinical and Biological Factors With Prognostic Value in Acute Pancreatitis. Journal of Mind and Medical Sciences. 2022; 9(2):310-317. https://doi.org/10.22543/2392-7674.1352
Chicago/Turabian StyleFaur, Mihai, Dan Dumitrescu, Dan Sabau, Ciprian Tanasescu, Dan Cretu, Denisa Tanasescu, Vlad Denis Constantin, and Calin Mohor. 2022. "Clinical and Biological Factors With Prognostic Value in Acute Pancreatitis" Journal of Mind and Medical Sciences 9, no. 2: 310-317. https://doi.org/10.22543/2392-7674.1352
APA StyleFaur, M., Dumitrescu, D., Sabau, D., Tanasescu, C., Cretu, D., Tanasescu, D., Constantin, V. D., & Mohor, C. (2022). Clinical and Biological Factors With Prognostic Value in Acute Pancreatitis. Journal of Mind and Medical Sciences, 9(2), 310-317. https://doi.org/10.22543/2392-7674.1352